Tolerance-like innate immunity and spleen injury: a novel discovery via the weekly administrations and consecutive injections of PEGylated emulsions

Abstract

There has been an increasing interest in the study of the innate immune system in recent years. However, few studies have focused on whether innate immunity can acquire tolerance. Therefore, in this study, we investigated tolerance in the innate immune system via the consecutive weekly and daily injections of emulsions modified with polyethylene glycol (PEG), referred to as PEGylated emulsions (PE). The effects of these injections of PE on pharmacokinetics and biodistribution were studied in normal and macrophage-depleted rats. Additionally, we evaluated the antigenic specificity of immunologic tolerance. Immunologic tolerance against PE developed after 21 days of consecutive daily injections or the fourth week of PE administration. Compared with a single administration, it was observed that the tolerant rats had a lower rate of PE clearance from the blood, which was independent of the stress response. In addition, weekly PE injections caused injury to the spleen. Furthermore, the rats tolerant to PEs with the methoxy group (–OCH3) of PEG, failed to respond to the PEs with a different terminal group of PEG or to non-PEG emulsions. Innate immunity tolerance was induced by PE, regardless of the mode of administration. Further study of this mechanism suggested that monocytes play an essential role in the suppression of innate immunity. These findings provide novel insights into the understanding of the innate immune system.

Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery

“…Based on these known immunosuppressive effects of PEG, it is possible that PEG components of nanoparticles may contribute to carrier-induced suppression of antitumor immunity. This hypothesis is supported by a recent report that PEG-lipid nanoemulsions (mean particle size 125 nm) induced immunologic tolerance that was mediated by macrophages ( Wang et al, 2014 ). However, this study did not include a non-PEG lipid control, and it is unclear whether these immunosuppressive effects were due to PEG, lipid, or both components.…”

Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate

“…Moreover, recent evidence in patients with ovarian cancer showed that circulating monocyte numbers and plasma CCL2 levels correlated with PLD clearance [37] and plasma PLD levels [63], respectively. In addition, CCL2 knockout mice bearing ovarian tumor xenografts were found to have altered clearance of PLD as compared to control mice [62,63]. These data further support a link between PLN uptake by myeloid cells of the monocyte-macrophage lineage and their immune functionality.…”

Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights

“…A lower index indicates faster elimination in blood and a more severe ABC phenomenon. To describe the extent of the ABC phenomenon more intuitively, we suggested a four-level division based on the ABC index within 30 min: 0–0.5 for a significant ABC phenomenon, 0.5–0.7 for a moderate ABC phenomenon, 0.7–0.9 for a weak ABC phenomenon, and 0.9–1.0 for no ABC phenomenon. , In this study, we calculated the ABC index with final times ranging from 15 to 720 min (data not shown). We determined that the ratio of AUCs was more comparable within 60 min than within 30 min, suggesting that AUC (0–60min) was a suitable parameter for assessing the magnitude of the ABC phenomenon.…”